Filter announcements
Loading...
Incorporated in 1986, Ortin Laboratories Ltd is engaged in the manufacturing and trading of Pharmaceuticals, Drugs and Intermediates.
Rarever Financial Advisors Pvt. Ltd. (Manager to the Offer) has submitted to the Exchange a copy of Recommendations of the Committee of Independent Directors on the Open Offer of Ortin Global Limited (Target Company).
Ortin Global clarifies it's not a 'Large Corporate' as its long-term borrowings are below ₹1,000 Cr. This means the company is exempt from specific disclosures mandated for larger entities.
Ortin Global Limited informed the exchange there are no new operational changes, business developments, or price-sensitive information impacting the company's performance. The company clarified that recent share price movements are not attributable to any extraordinary internal events. Management affirmed that any significant future developments will be promptly disclosed. This update...
ORTIN GLOBAL LIMITED has informed the Exchange about General Updates
Ortin Global Limited has announced a board meeting to approve the financial results for the quarter and half-year. The company reported a net loss of Rs 16.41 lakh for the quarter and Rs 414.48 lakh for the year, indicating ongoing operational challenges. The Board appointed M/s. Aakanksha Dubey & Co...